Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VEEC-84 by Defender Pharmaceuticals for Venezuelan Equine Encephalitis: Likelihood of Approval
VEEC-84 is under clinical development by Defender Pharmaceuticals and currently in Phase II for Venezuelan Equine Encephalitis. According to GlobalData,...